The shortage of stimulant-based ADHD (Attention Deficit Hyperactivity Disorder) medications like Adderall, Vyvanse and Ritalin persists, with leading drug makers unable to provide a solution. The ...

NPR's Leila Fadel talks to Lina Khan, chair of the Federal Trade Commission, about drug companies holding patents on medications for much longer than they're supposed to. Most drug patents are meant ...

Although most cancer drugs modulate the activity of enzymes that regulate post-translational modifications (PTMs), little systematic information is available about drug action at the level of PTMs. To ...

Section 1. Purpose. The United States has less than five percent of the world’s population and yet funds around three quarters of global pharmaceutical profits. This egregious imbalance is ...

Although VDZ is a front-line drug and has been successfully prescribed around the world, its broader mechanism of action has remained unclear. The drug works by binding to the cellular site that it ...

Antibody-drug conjugates (ADCs) are a rapidly emerging class of therapeutic agents that combine the target specificity of a monoclonal antibody (mAb) with the lethality of cytotoxic cellular poison.

Eli Lilly’s donanemab was expected to be approved this month, but the agency has decided to convene a panel of independent experts to evaluate the drug’s safety and efficacy. By Pam Belluck Pam ...

MONTREAL — The deadline is fast approaching for Canadians to claim their share of a multimillion-dollar class-action lawsuit ...

This press release was updated on 11 June 2026 to add the Conclusions on jointly operationalising the EU Drugs Strategy. Today, the Council approved a framework to implement the EU drugs strategy in ...